|
市場調査レポート
商品コード
1541500
新生児スクリーニング市場レポート：製品、技術、検査タイプ、地域別、2024年～2032年Newborn Screening Market Report by Product, Technology, Test Type, and Region 2024-2032 |
||||||
カスタマイズ可能
|
|||||||
| 新生児スクリーニング市場レポート：製品、技術、検査タイプ、地域別、2024年～2032年 |
|
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
新生児スクリーニングの世界市場規模は2023年に10億2,660万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに17億7,770万米ドルに達し、2024年から2032年の間に6.1％の成長率（CAGR）を示すと予測しています。新生児の重篤な疾患の早期発見に対する個人の意識の高まり、より正確な結果を得るための医療技術の向上、有利な政府の取り組みなどが市場成長を促進する要因となっています。
世界の新生児スクリーニング市場分析：
主な市場促進要因：代謝性疾患や遺伝性疾患の有病率の増加と出生率の増加が、主に新生児スクリーニング市場のシェアを押し上げています。これとは別に、ヘルスケアコストの削減と転帰の改善をもたらすスクリーニング検査に対する需要の高まりも、重要な成長促進要因として作用しています。
主な市場動向：新生児スクリーニングの効率を向上させるためのデータ管理・分析ツールの統合の高まりは、新生児スクリーニング市場の見通しを強化する新たな動向の一つです。さらに、予防ヘルスケア対策と全人的な幸福を重視する親の増加も、新生児スクリーニング市場の需要をさらに押し上げています。
地理的動向：新生児スクリーニング市場調査レポートによると、北米は高度なヘルスケアインフラの存在により、明確な優位性を示しています。これに加え、有利な政府の取り組みや規制が、この地域市場にさらにプラスの影響を与えています。
競合情勢：世界の新生児スクリーニング市場における主要企業には、Agilent Technologies Inc.、Baebies Inc.、Bio-RAD Laboratories Inc.、Chromsystems Instruments &Chemicals GmbH、Danaher Corporation、Masimo Corporation、Medtronic plc、Natus Medical Incorporated、Perkinelmer Inc.、RECIPE Chemicals+Instruments GmbH、Thermo Fisher Scientific Inc.、Trivitron Healthcare、Waters Corporationなどがあります。
課題と機会：新生児スクリーニング市場を妨げている主な課題の一つは、新生児スクリーニング検査が多くの国や地域で標準化されていないことです。これに加えて、データのプライバシーや同意など、法的・倫理的な配慮が、新生児スクリーニング・プログラムの拡大・実施における課題となりうる。しかし、幅広い潜在的な健康問題に効率的に対処できるような有利なイニシアチブの立ち上げが、予測期間中の世界市場を拡大すると予測されます。
世界の新生児スクリーニング市場動向：
病気の早期発見に対する意識の高まり
早期発見が治療成績の向上、子供のQOLの向上、タイムリーな介入などに役立つことから、早期発見が極めて重要であるという保護者の意識が高まっていることは、新生児スクリーニング市場を強化する主要な促進要因の一つです。これに加えて、先天性疾患の増加も、もう一つの重要な成長促進要因として作用しています。例えば、WHOが2023年2月に発表したデータによると、先天性疾患が原因で毎年生後28日以内に死亡する新生児は世界全体で推定24万人です。さらに、Indian Pediatricsの情報によると、インドでは先天性甲状腺機能低下症が乳児1,000人のうち2.1人に見られ、先天性代謝異常の有病率は2～7.8％です。
政府の好意的な取り組み
規制当局による政策の開始は、多くの場合、疾患の包括的なパネルをカバーし、潜在的な健康問題が効率的に対処されることを保証するものであり、世界の新生児スクリーニング市場を強化しています。例えば、2022年6月、カナダのマニトバ州の政府機関は、他の疾患とともに脊髄性筋萎縮症のスクリーニングを拡大する目的で、新生児スクリーニングプログラムの拡大を発表しました。さらに、さまざまな政府当局が退院前の新生児スクリーニングを義務化し、市場全体の成長にプラスの影響を与えています。例えば、2021年のMarch of Dimes（MoD）の報告書によると、米国では退院前にすべての赤ちゃんがスクリーニングを受けています。さらに、テキサス州、カリフォルニア州、ニューヨーク州の新生児スクリーニングプログラムも米国全土で広範な支持を集めており、予測期間中も新生児スクリーニング市場を牽引し続けると思われます。
医療技術の向上
主要企業は、新生児スクリーニング方法を改善するために医療技術を進歩させており、これも重要な成長促進要因として作用しています。さらに、新たなスクリーニング技術は、医療提供者がこれらのサービスを提供し、採用することを促し、それによって世界市場を活性化させています。例えば、2021年6月、テキサス州保健福祉局は脊髄性筋萎縮症（SMA）の新生児スクリーニングを導入しました。これに伴い、トリビトロン・ヘルスケアはインドのAMTZキャンパスに、ゲノム、新生児スクリーニング、メタボロミクス、分子診断のための最先端の研究開発・製造施設を備えたセンター・オブ・エクセレンス（CoE）を開発しました。さらに、マシモは2023年1月、赤ちゃんのデータをリアルタイムでモニターできる最先端のベビーモニタリングシステムの発売を発表しました。
本レポートで扱う主な質問
- 2023年の世界の新生児スクリーニング市場の市場規模は？
- 2024-2032年における新生児スクリーニング市場の世界市場予測成長率は？
- 新生児スクリーニング市場の世界市場を牽引する主要因は何か
- 世界の新生児スクリーニング市場に対するCOVID-19の影響は？
- 新生児スクリーニング市場の製品別内訳は？
- 世界の新生児スクリーニング市場の技術別内訳は？
- 世界の新生児スクリーニング市場の検査タイプ別内訳は？
- 新生児スクリーニング市場の世界における主要地域はどこか
- 新生児スクリーニング市場の世界における主要プレイヤー/企業は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界の新生児スクリーニング市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：製品別
- 機器
- 市場動向
- 市場予測
- 試薬
- 市場動向
- 市場予測
第7章 市場内訳：技術別
- タンデム質量分析法
- 市場動向
- 市場予測
- パルスオキシメトリー
- 市場動向
- 市場予測
- 酵素ベースのアッセイ
- 市場動向
- 市場予測
- DNA検査
- 市場動向
- 市場予測
- 電気泳動
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第8章 市場内訳：テストタイプ別
- ドライブラッドスポットテスト
- 市場動向
- 市場予測
- CCHD
- 市場動向
- 市場予測
- 聴覚スクリーン
- 市場動向
- 市場予測
第9章 市場内訳：地域別
- 北米
- 米国
- カナダ
- アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測
第10章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第11章 バリューチェーン分析
第12章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第13章 価格分析
第14章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Agilent Technologies Inc.
- Baebies Inc.
- Bio-RAD Laboratories Inc.
- Chromsystems Instruments & Chemicals GmbH
- Danaher Corporation
- Masimo Corporation
- Medtronic plc
- Natus Medical Incorporated
- Perkinelmer Inc.
- RECIPE Chemicals+Instruments GmbH
- Thermo Fisher Scientific Inc.
- Trivitron Healthcare
- Waters Corporation
List of Figures
- Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
- Figure 2: Global: Newborn Screening Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2023
- Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2023
- Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2023
- Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2023
- Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: North America: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: United States: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Canada: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: China: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Japan: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: India: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Australia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Europe: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Germany: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: France: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Italy: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Spain: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Russia: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Others: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2023
- Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Global: Newborn Screening Industry: SWOT Analysis
- Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
- Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million US$), 2024-2032
- Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
- Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Newborn Screening Market: Competitive Structure
- Table 7: Global: Newborn Screening Market: Key Players
The global newborn screening market size reached US$ 1,026.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,777.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The increasing awareness among individuals towards early detection of severe diseases in newborns, improvements in medical technology for more accurate outcomes, and favorable government initiatives represent some of the key drivers bolstering the market growth.
Global Newborn Screening Market Analysis:
Major Market Drivers: The growing prevalence of metabolic and genetic disorders and the increasing birth rates are primarily driving the newborn screening market share. Apart from this, the escalating demand for screening tests that provide reduced healthcare costs and improved outcomes is also acting as another significant growth-inducing factor.
Key Market Trends: The rising integration of data management and analysis tools to improve the efficiency of newborn screening is one of the emerging trends bolstering the newborn screening market outlook. Additionally, the inflating emphasis on preventive healthcare measures and holistic well-being among parents is further propelling the newborn screening market demand.
Geographical Trends: According to the newborn screening market research report, North America exhibits a clear dominance, owing to the presence of advanced healthcare infrastructures. Besides this, favorable government initiatives and regulations are further positively influencing the regional market.
Competitive Landscape: Some of the key players in the global newborn screening market include Agilent Technologies Inc., Baebies Inc., Bio-RAD Laboratories Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, Perkinelmer Inc., RECIPE Chemicals + Instruments GmbH, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Waters Corporation, among many others.
Challenges and Opportunities: One of the primary challenges hindering the newborn screening market is the lack of standardization in newborn screening tests across numerous countries and regions. Besides this, legal and ethical considerations, including data privacy and consent, can pose challenges in expanding and implementing newborn screening programs. However, the launch of favorable initiatives that ensure that a wide range of potential health issues are addressed efficiently is projected to augment the global market over the forecasted period.
Global Newborn Screening Market Trends:
Increasing Awareness about Early Disease Detection
The growing awareness among parents towards the critical importance of early disease detection, as it helps in enhancing treatment outcomes, improving quality of life for the child, offering timely intervention, etc., represents one of the primary drivers bolstering the newborn screening market. Besides this, the rising occurrence of congenital diseases is also acting as another significant growth-inducing factor. For example, according to the data published by the WHO in February 2023, an estimated 240,000 newborns die within 28 days of birth each year globally due to congenital diseases. Moreover, according to the information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2-7.8%.
Favorable Government Initiatives
The launch of policies by regulatory authorities that often cover a comprehensive panel of disorders and ensure that potential health issues are addressed efficiently is bolstering the global newborn screening market. For example, in June 2022, government bodies in Manitoba, Canada, announced the expansion of their newborn screening program with an aim to extend screening for spinal muscular atrophy, along with other diseases. Moreover, various government authorities have also made newborn screening compulsory before getting discharged from the hospital, thereby positively impacting the overall market growth. For instance, according to the March of Dimes (MoD) report of 2021, before leaving the hospital, every baby in the United States went through the screening process. Furthermore, newborn screening programs in Texas, California, and New York also gained extensive traction across the U.S., which will continue to drive the newborn screening market over the forecasted period.
Improvements in Medical Technology
Key players are advancing their medical technologies to improve newborn screening methods, which is acting as another significant growth-inducing factor. Moreover, emerging screening technologies encourage healthcare providers to offer and adopt these services, thereby fueling the global market. For example, in June 2021, the Texas Health and Human Services introduced newborn screening for Spinal Muscular Atrophy (SMA). In line with this, Trivitron Healthcare developed a Centre of Excellence (CoE) with state-of-the-art R&D and manufacturing facilities at AMTZ Campus in India for genomics, newborn screening, metabolomics, and molecular diagnostics. Furthermore, in January 2023, Masimo announced the launch of its new state-of-the-art baby monitoring system that allows caretakers to monitor the data of babies in real-time.
Global Newborn Screening Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology and test type.
Breakup by Product:
Instruments
Reagents
Instruments represent the largest market segment
The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments and reagents. According to the report, instruments accounted for the largest market share.
Instruments play a crucial role in the screening process for sample collection, analysis, result interpretation, etc. In addition to this, they comprise a wide array of technologies, such as deoxyribonucleic acid (DNA) analyzers, automated screening platforms, mass spectrometry systems, etc. Moreover, the rising investments by key healthcare companies in diagnostics tests that require instruments are expected to bolster the market growth in this segmentation. For instance, in March 2023, GC Labs announced the launch of its new test for the diagnosis of Inborn Errors of Metabolism (IEM) among newborns with the integration of novel disease detection methods.
Breakup by Technology:
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assay
DNA Assay
Electrophoresis
Others
Tandem mass spectrometry accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the technology. This includes tandem mass spectrometry, pulse oximetry, enzyme based assay, DNA assay, electrophoresis, and others. According to the report, tandem mass spectrometry accounted for the largest market share.
Tandem mass spectrometry refers to an analytical technique that is employed in newborn screening to identify several metabolic disorders. In line with this, it provides improved accuracy and speed. Numerous technological advancements in the medical field enhance tandem mass spectrometry, which will continue to drive the market growth in this segmentation. For example, in April 2023, Waters Corporation announced the development of its new Xevo TQ Absolute IVD Mass Spectrometer for clinical applications.
Breakup by Test Type:
Dry Blood Spot Test
CCHD
Hearing Screen
Dry blood spot test holds the biggest market share
The report has provided a detailed breakup and analysis of the market based on the test type. This includes dry blood spot test, CCHD, and hearing screen. According to the report, the dry blood spot test accounted for the largest market share.
A dry blood spot test refers to a non-invasive screening technique that generally involves collecting a small amount of blood from the heel of a newborn onto a special filter paper. The dried blood sample is then analyzed for the presence of specific markers associated with several disorders. The test is widely preferred among newborn screening programs, as it provides ease of transportation, convenience of sample collection, and the ability to simultaneously screen for various conditions. Besides this, the elevating number of initiatives by government bodies is acting as another significant growth-inducing factor in this segmentation.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest newborn screening market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The increasing prevalence of congenital disabilities in North America is augmenting the need for newborn screening. Moreover, the implementation of stringent regulations by government bodies across the region is also acting as another significant growth-inducing factor. For example, according to the March of Dimes (MoD) report of 2021, before leaving the hospital, every baby in the United States went through the screening process. Apart from this, the elevating focus of key players on preventive healthcare is inflating the popularity of advanced technologies, which is expected to bolster the North America newborn screening market over the foreseeable future.
Competitive Landscape:
Various manufacturers are investing in research and development (R&D) activities to provide innovative screening technologies and methods. This includes refining existing techniques like tandem mass spectrometry and exploring new approaches to broaden the scope of conditions detected. In addition, companies are providing a more comprehensive screening service by adding more conditions to their test panels. Apart from this, key players are also focusing on developing automated systems that streamline the screening process, from sample collection to result interpretation, to enhance efficiency, reduce human error, and allow for faster turnaround times.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Agilent Technologies Inc.
Baebies Inc.
Bio-RAD Laboratories Inc.
Chromsystems Instruments & Chemicals GmbH
Danaher Corporation
Masimo Corporation
Medtronic plc
Natus Medical Incorporated
Perkinelmer Inc.
RECIPE Chemicals + Instruments GmbH
Thermo Fisher Scientific Inc.
Trivitron Healthcare
Waters Corporation
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Global Newborn Screening Market News:
March 2024: The World Health Organization (WHO) launched implementation guidance in Southeast Asia for universal screening of eye abnormalities, hearing impairment, and neonatal jaundice among newborns.
February 2024: Niloufer Hospital in Hyderabad introduced a newborn screening program to detect rare genetic conditions.
February 2024: A research study titled Early Check has screened 1,000 newborns after birth to provide treatment, give parents educational information, identify rare conditions early, and connect families with specialists throughout the state of North Carolina.
Key Questions Answered in This Report
- 1. What was the size of the global newborn screening market in 2023?
- 2. What is the expected growth rate of the global newborn screening market during 2024-2032?
- 3. What are the key factors driving the global newborn screening market?
- 4. What has been the impact of COVID-19 on the global newborn screening market?
- 5. What is the breakup of the global newborn screening market based on the product?
- 6. What is the breakup of the global newborn screening market based on the technology?
- 7. What is the breakup of the global newborn screening market based on the test type?
- 8. What are the key regions in the global newborn screening market?
- 9. Who are the key players/companies in the global newborn screening market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Newborn Screening Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Tandem Mass Spectrometry
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Pulse Oximetry
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Enzyme Based Assay
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 DNA Assay
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Electrophoresis
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Test Type
- 8.1 Dry Blood Spot Test
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 CCHD
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Hearing Screen
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Agilent Technologies Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Baebies Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Bio-RAD Laboratories Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Chromsystems Instruments & Chemicals GmbH
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Danaher Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Masimo Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Medtronic plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Natus Medical Incorporated
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Perkinelmer Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 RECIPE Chemicals + Instruments GmbH
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Thermo Fisher Scientific Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Trivitron Healthcare
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.13 Waters Corporation
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
- 14.3.1 Agilent Technologies Inc.
